Bronchopneumonia
Learn about bronchopneumonia, also known as bronchial pneumonia or lobular pneumonia. This resource provides information on diagnosis, clinical documentation, and medical coding for bronchopneumonia, focusing on healthcare best practices and terminology commonly used in medical settings. Find details relevant to pneumonia symptoms, treatment, and accurate coding for optimal patient care.
Lung infection affecting bronchi and surrounding alveoli, often following a viral upper respiratory infection.
Cough, fever, shortness of breath, chest pain, rapid breathing, wheezing, and crackles on lung auscultation.
Community-acquired, hospital-acquired, or healthcare-associated settings. Seen in individuals with weakened immune systems.
ICD-10 Code Families
Complete code families applicable to J18.0
When to use each related code
| Description | When to use |
|---|---|
| Lung infection affecting bronchi and alveoli. | Inflammation in both bronchi and lung tissue, patchy distribution on imaging. Use when lobar consolidation absent. |
| Lung infection affecting one or more lobes. | Consolidation affecting a whole lobe or more, typically bacterial. Search terms: pneumonia, lobar consolidation |
| Lung infection scattered throughout, often viral. | Diffuse, patchy infiltrates on imaging. Consider in patients with flu-like symptoms. Search terms: atypical pneumonia, interstitial pneumonia |
Best-practice checklist
- ✓Bronchopneumonia diagnosis: Document symptom onset
- ✓Bronchopneumonia: Physical exam findings (e.g., rales)
- ✓Bronchopneumonia: Chest X-ray or CT scan results
- ✓Lobular pneumonia: Document causative agent if known
- ✓Bronchial pneumonia: Specify lobe/segment involvement
Common pitfalls to avoid
Coding bronchopneumonia without specifying the causative organism when documented leads to inaccurate severity and treatment reflection.
Miscoding bronchopneumonia as simple pneumonia can underrepresent severity and impact quality metrics and reimbursement.
Failing to code associated comorbidities like asthma or COPD with bronchopneumonia can affect risk adjustment and resource allocation.
Best-practice tips
- 01Document pneumonia type, location, and severity for accurate ICD-10 coding (J18.-).
- 02Ensure CDI aligns documentation with clinical findings for proper reimbursement.
- 03Follow antibiotic stewardship guidelines for appropriate pneumonia treatment and compliance.
- 04Timely blood cultures and imaging aid diagnosis and guide appropriate therapy.
- 05For aspiration pneumonia, assess swallowing function and implement preventive measures.
Step-by-step checklist
- 1
Confirm symptoms: cough, fever, chest pain, sputum production (ICD-10: J18.0)
- 2
Auscultate lungs for crackles, rhonchi (patient safety: thorough exam)
- 3
Check chest X-ray for patchy infiltrates consistent with bronchopneumonia (clinical documentation: imaging results)
- 4
Consider sputum culture, blood tests for diagnosis confirmation (medical coding: specify organism if identified)
- 5
Assess patient risk factors: age, smoking, comorbidities (patient safety: guide treatment)
Ready-to-paste narrative
Patient presents with symptoms consistent with bronchopneumonia, also known as bronchial pneumonia or lobular pneumonia. The patient reports productive cough with purulent sputum, shortness of breath (dyspnea), pleuritic chest pain, fever, chills, and malaise. Physical examination reveals crackles and rhonchi on auscultation, along with increased respiratory rate and tachycardia. Differential diagnosis includes community-acquired pneumonia, atypical pneumonia, bronchitis, and influenza. Chest X-ray demonstrates patchy infiltrates consistent with bronchopneumonia, primarily affecting the bronchioles and surrounding alveoli. Laboratory findings indicate leukocytosis. Based on clinical presentation, physical exam, and radiological findings, a diagnosis of bronchopneumonia is established. Treatment plan includes antibiotic therapy with appropriate respiratory support as needed. Patient education provided on medication adherence, hydration, rest, and follow-up care. ICD-10 code J18.0 is documented for billing and coding purposes. Prognosis is generally favorable with appropriate treatment, and patient is instructed to monitor symptoms and return for reevaluation if condition worsens or does not improve within the expected timeframe. Potential complications including pleural effusion, empyema, and respiratory failure have been discussed with the patient.
Common questions and answers
What are the key differentiating factors in diagnosing bronchopneumonia vs. lobar pneumonia in adults?+
Differentiating bronchopneumonia (also known as bronchial pneumonia) from lobar pneumonia requires careful consideration of clinical presentation, radiological findings, and sometimes, microbiological data. Bronchopneumonia typically presents with a patchy distribution of inflammation affecting multiple bronchioles and surrounding alveoli, often in different lobes. This contrasts with lobar pneumonia, which involves consolidation of an entire lobe of the lung. Clinically, bronchopneumonia may present with more insidious onset, productive cough, and diffuse crackles on auscultation. Lobar pneumonia often presents with a more acute onset, high fever, chills, and pleuritic chest pain. Radiographically, bronchopneumonia shows patchy infiltrates or consolidations scattered throughout the lungs, whereas lobar pneumonia presents as a dense consolidation affecting a whole lobe. Explore how computed tomography (CT) scans can further aid in distinguishing these conditions and characterizing the extent of pulmonary involvement. Consider implementing a systematic approach to pneumonia diagnosis, integrating clinical findings, imaging, and laboratory results for accurate differentiation and tailored treatment strategies.
How do I effectively manage antibiotic-resistant bronchopneumonia in hospitalized elderly patients with comorbidities?+
Managing antibiotic-resistant bronchopneumonia in elderly hospitalized patients with comorbidities presents a significant challenge. Initial antibiotic choices should be guided by local resistance patterns and the patient's specific risk factors. Consider obtaining cultures (blood and sputum) before initiating empiric therapy. If methicillin-resistant Staphylococcus aureus (MRSA) or Pseudomonas aeruginosa are suspected, consider broader-spectrum antibiotics like vancomycin or antipseudomonal agents, respectively. Closely monitor the patient's clinical response, including oxygen saturation, respiratory rate, and white blood cell count. For patients not responding to initial therapy within 48-72 hours, consider further investigations such as repeat cultures and chest imaging to evaluate for complications like empyema or abscess formation. Optimize supportive care, including oxygen therapy, fluid management, and nutritional support. Learn more about the role of combination antibiotic therapy and the potential benefits and risks associated with its use in complex cases of resistant bronchopneumonia. Explore how implementing antimicrobial stewardship protocols can help minimize the emergence and spread of resistance in healthcare settings.
What are the most effective diagnostic tests for identifying the causative pathogens in bronchopneumonia, including atypical causes?+
Identifying the causative pathogen in bronchopneumonia can be crucial for guiding targeted antibiotic therapy, especially when atypical pathogens are suspected. Sputum culture and Gram stain remain valuable initial diagnostic tests, helping identify common bacterial pathogens like Streptococcus pneumoniae and Haemophilus influenzae. However, these tests may not be sensitive for detecting atypical pathogens such as Mycoplasma pneumoniae, Chlamydophila pneumoniae, and Legionella pneumophila. In cases where atypical pneumonia is suspected, consider serological testing for specific antibodies against these organisms. Polymerase chain reaction (PCR) testing on respiratory samples can also provide rapid and sensitive detection of both typical and atypical pathogens. Urinary antigen testing is particularly useful for diagnosing Legionella infection. Consider implementing diagnostic algorithms that integrate clinical findings, imaging features, and available laboratory resources to guide the selection of appropriate diagnostic tests. Explore how bronchoscopy with bronchoalveolar lavage (BAL) can be utilized in specific cases to obtain samples for microbiological analysis when less invasive methods are inconclusive. Consider implementing strategies to improve sputum sample quality to enhance the diagnostic yield of conventional cultures.
Clinical accuracy: This information is provided for documentation and coding guidance and should not replace professional medical judgment.
Coding standard: ICD-10-CM, current FY guidelines.